Search

Your search keyword '"SCHNEIDER, RAYFEL"' showing total 457 results

Search Constraints

Start Over You searched for: Author "SCHNEIDER, RAYFEL" Remove constraint Author: "SCHNEIDER, RAYFEL"
457 results on '"SCHNEIDER, RAYFEL"'

Search Results

2. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis

3. Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses

4. Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth

5. Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis

9. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test

10. Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology

11. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

12. Lengthening sleep reduces pain in childhood arthritis: a crossover randomised controlled trial

14. A curious case of growth failure and hypercalcemia: Answers

16. Contributors

17. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey

21. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort

23. Contributors

25. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

26. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

27. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

28. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

32. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

33. Additional file 1 of Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis

37. Systemic juvenile idiopathic arthritis is associated with HLA-DRB1 in Europeans and Americans of European descent

38. Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

41. Contributors

43. Characterization Of Changes In Gene Expression and Inflammatory Proteins In Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy.: 1692

45. CONTRIBUTORS

47. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

48. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

49. Clinical and Psychosocial Stress Factors are Associated with Decline in Physical Activity Over Time in Children with Juvenile Idiopathic Arthritis

50. Comparing Apples to Apples in Post-COVID-Associated Multisystem Inflammatory Syndrome in Children (MIS-C)

Catalog

Books, media, physical & digital resources